Integrating radiomics and dosiomics with lung biologically equivalent dose for predicting symptomatic radiation pneumonitis after lung SBRT: A dual-center study

Abstract

Background and purpose

This study focused on developing and validating a composite model that integrates radiomic and dosiomic features based on a lung biologically equivalent dose segmentation approach to predict symptomatic radiation pneumonitis (SRP) following lung SBRT.

Materials and methods

A dual-centered cohorts of 182 lung cancer patients treated with SBRT were divided into training, validation, and external testing sets. Radiomic and dosiomic features were extracted from two distinct regions of interest (ROIs) in the planning computed tomography (CT) images and 3D dose distribution maps, which encompassed both the entire lung and biologically equivalent dose (BED) regions. Feature selection involved correlation filters and LASSO regularization. Five machine learning algorithms generated three individual models (dose-volume histogram [DVH], radiomic [R], dosiomic [D]) and three combined models (R + DVH, R + D, R + D + DVH). Performance was evaluated via ROC analysis, calibration, and decision curve analysis.

Results

Among the clinical and dosimetric factors, V_BED70 (α/β = 3 Gy) of the lung was recognized as an independent risk factor for SRP. BED-based radiomic and dosiomic models outperformed whole-lung models (AUCs: 0.806 vs. 0.674 and 0.821 vs. 0.647, respectively). The R + D + DVH trio model achieved the highest predictive accuracy (AUC: 0.889, 95 % CI: 0.701–0.956), with robust calibration and clinical utility.

Conclusions

The R + D + DVH trio model based on lung biologically equivalent dose segmentation approach outperforms other models in predicting SRP across various SBRT fractionation schemes.